Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jacqueline T. Bork"'
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 3, Pp 989-996 (2023)
Abstract Introduction Numerous patients have cultures pending at discharge which, if not addressed, may delay diagnosis and initiation of appropriate antimicrobials. The purpose of the study is to evaluate the appropriateness of discharge antimicrobi
Externí odkaz:
https://doaj.org/article/ffaedbe482a44510b5dc704c9bd02be7
Autor:
Chelsea S. Lynch, Andrea Appleby-Sigler, Jacqueline T. Bork, Rohini Davé, Kathy Agnes, Molly Sanikop, Doris Heath, Arlene F. Clark, Kimberly Claeys, Min Zhan, Daniel J. Morgan
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-6 (2020)
Abstract Background Urine cultures are often positive in the absence of a urinary tract infection (UTI). Pyuria is generally considered necessary to diagnose a UTI. Problem Urine cultures are often positive in the absence of UTI leading to unnecessar
Externí odkaz:
https://doaj.org/article/9966a3291bae49fbb65f1ba1b1f09348
Autor:
Jacqueline T. Bork, Emily L. Heil, Shanna Berry, Eurides Lopes, Rohini Davé, Bruce L. Gilliam, Anthony Amoroso
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 2, Pp 171-184 (2019)
Abstract Introduction Dalbavancin is approved for acute bacterial skin and skin structure infections (ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive infections. Importantly, dalbavancin’s real benefits may b
Externí odkaz:
https://doaj.org/article/40b56d21610844b58ab38b3e6307ca1b
Publikováno v:
Open Forum Infectious Diseases. 9
Background Candidemia is an important cause of morbidity and mortality. Fluconazole resistance is associated with increased mortality in candidemia and thus echinocandins are recommended as first line empiric therapy. To understand the current landsc
Publikováno v:
Current Treatment Options in Infectious Diseases. 13:111-122
We aim to discuss the evidence behind combination therapy as well as to describe the novel antifungals used in the treatment for mucormycosis. In patients with advanced or refractory invasive mucormycosis, limited data support the use of combination
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(5)
Diagnostic stewardship in solid organ transplant (SOT) recipients has the potential to help these vulnerable patients at risk for over-testing and overtreatment.Herein, we review potential targets for diagnostic stewardship in SOT, such as Clostridio
Publikováno v:
Open forum infectious diseases. 9(7)
Background Prospective audit with feedback (PAF) is an impactful strategy for antimicrobial stewardship program (ASP) activities. However, because PAF requires reviewing large numbers of antimicrobial orders on a case-by-case basis, PAF programs are
Autor:
Lauren Groft Buzzalino, James Mease, Ciera L Bernhardi, Jacqueline T Bork, J Kristie Johnson, Kimberly C Claeys
Publikováno v:
Open forum infectious diseases. 9(5)
The role of follow-up blood cultures (FUBCs) in gram-negative bloodstream infections to improve clinical outcomes remains controversial, especially among immunocompromised patients. Among 139 patients, FUBCs were common (117, 84.2%); however, positiv
Publikováno v:
Open Forum Infectious Diseases
Human herpesvirus 6 (HHV-6) reactivation can occur in patients who are highly immunosuppressed, including those who have undergone hematopoietic stem cell transplantation (HSCT). HHV-6 encephalitis is a severe manifestation that is well described in
Autor:
Anthony Amoroso, Bruce L. Gilliam, Jacqueline T. Bork, Eurides Lopes, Emily L. Heil, Rohini Dave, Shanna Berry
Publikováno v:
Infectious Diseases and Therapy
Infectious Diseases and Therapy, Vol 8, Iss 2, Pp 171-184 (2019)
Infectious Diseases and Therapy, Vol 8, Iss 2, Pp 171-184 (2019)
Introduction Dalbavancin is approved for acute bacterial skin and skin structure infections (ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive infections. Importantly, dalbavancin’s real benefits may be in trea